Mayne Pharma Group Market Cap

Mayne Pharma Group has a market cap or net worth of 260.80 million as of December 5, 2025. Its market cap has decreased by -30.97% in one year.

Market Cap

260.80M

Enterprise Value

201.67M

Revenue

408.10M

Ranking

n/a

PE Ratio

n/a

Stock Price

3.21

Market Cap Chart

Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 260.80M, an increase of 471.18%. That is a compound annual growth rate of 9.91%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	260.80M	-35.41%
Dec 31, 2024	403.79M	-19.19%
Dec 29, 2023	499.66M	43.60%
Dec 30, 2022	347.96M	-33.16%
Dec 31, 2021	520.63M	-10.12%
Dec 31, 2020	579.28M	-20.69%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CSL Limited	88.88B
Pro Medicus	26.02B
Cochlear	17.62B
Sonic Healthcare	11.42B
Ramsay Health Care	8.33B
Ansell	5.15B
Telix Pharmaceuticals	5.02B
Mesoblast	3.41B

Market Cap Rankings